27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Biotech stocks advanced in the week ended July 17 thanks to positive broader market sentiment, encouraging news flow on the COVID-19 front and fairly positive results reported by pharma giant Johnson & Johnson (NYSE:JNJ).
Equillium Inc (NASDAQ:EQ) was among the biggest gainers of the week after a drug that it licensed from Biocon was granted emergency use authorization in India for treating cytokine release syndrome in COVID-19 patients with moderate to severe acute respiratory distress syndrome.
Moderna Inc (NASDAQ:MRNA) advanced in all five sessions of the week, with detailed interim Phase 1 data publication, positive sell-side commentary and news of inclusion in the Nasdaq 100 Index serving as catalysts.
The following are key catalysts in the unfolding week.
Conferences
Galactosemia Foundation 2020 Virtual Conference, July 17-19
PDUFA Dates
The FDA is set to rule on Jazz Pharmaceuticals PLC's (NASDAQ:JAZZ) NDA for JZP-258, which is being evaluated as a treatment option for cataplexy —excessive daytime sleepiness — in patients 7 and older with narcolepsy.
Earnings
- Biogen Inc (NASDAQ:BIIB) (Wednesday, before the market open)
- Quest Diagnostics Inc (NYSE:DGX) (Thursday, before the market open)
- West Pharmaceutical Services Inc. (NYSE:WST) (Thursday, before the market open)
- Edwards Lifesciences Corp (NYSE:EW) (Thursday, after the close)
- LeMaitre Vascular Inc (NASDAQ:LMAT) (Thursday, after the close)
IPOs
ACell, a regenerative medicines company that develops products designed to facilitate the body's ability to repair and remodel tissue, is planning a 5-million-share IPO at an estimated price range of $14-$16. The company has applied for listing its shares on the Nasdaq under the ticker symbol "ACLL."
IPO Quiet Period Expirations
- Polypid Ltd (NASDAQ:PYPD)
- Akouos Inc (NASDAQ:AKUS)
- Fusion Pharmaceuticals Inc (NASDAQ:FUSN)
- ADiTx Therapeutics Inc (NASDAQ:ADTX)
Related Links:
Researchers Say AbbVie's Tricor Reduced Severity Of COVID-19 Into 'Nothing Worse Than A Common Cold'
4 Ways Biogen's Tecfidera Generic Battle Could Play Out For The Stock
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!